reversible centriole depletion inhibitor polo-like kinase 
centrioles ancient organelles build centrosomes major microtubule-organizing centers animal cells extra centrosomes common feature cancer cells investigate importance centrosomes proliferation normal cancer cells developed centrinone reversible inhibitor polo-like kinase plk4 serine-threonine protein kinase initiates centriole assembly centrinone treatment caused centrosome depletion human vertebrate cells centrosome loss irreversibly arrested normal cells senescence-like g1 state p53-dependent mechanism independent dna damage stress hippo signaling extended mitotic duration segregation errors contrast cancer cell lines normal amplified centrosome numbers proliferate indefinitely centrosome loss upon centrinone washout cancer cell line returned intrinsic centrosome number "set point" thus cells cancer-associated mutations fundamentally differ normal cells response centrosome loss 
